Factors Influencing Compliance in Schizophrenia Patients

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 16, 2003, Pages 10-13

  Fleischhacker, W Wolfgang ^a   Oehl, Maria A ^a   Hummer, Martina ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL PRACTICE; CLINICAL PROTOCOL; CONFERENCE PAPER; CONTINUING EDUCATION; DEMOGRAPHY; DOCTOR PATIENT RELATION; DRUG INDUCED DISEASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENVIRONMENTAL FACTOR; HUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PREDICTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SCHIZOPHRENIA; SIDE EFFECT; SUPPORT GROUP; SYMPTOM; TECHNIQUE;

ANTIPSYCHOTIC AGENTS; HUMANS; PHYSICIAN-PATIENT RELATIONS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SICK ROLE; SOCIAL SUPPORT; TREATMENT REFUSAL;

EID: 0346753731     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Fleischhacker WW, Meise U, Günther V, et al. Compliance with antipsychotic drug treatment: influence of side-effects. Acta Psychiatr Scand Suppl 1994;382:11-15
2. Di Matteo MR, Di Nicola DD. Achieving Patient Compliance. New York, NY: Pergamon Press; 1982
3. Schwartz DM, Zeitz L, Gross ME. Medication errors made by elderly, chronically ill patients. Am J Public Health 1962;52:2018-2029
4. Riecher-Rössler A. Geschlechtsunterschiede bei Schizophrenien. Presented at the 3rd Congress "Psychiatrische Erkrankungen bei Frauen"; Nov 4-6, 1999; Basel, Switzerland
5. Schou M. The combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr Scand 1997;95:361-363
6. Miner CR, Rosenthal RN, Hellerstein DJ, et al. Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders. Arch Gen Psychiatry 1997;54:706-712
7. Tattan TM, Creed FH. Negative symptoms of schizophrenic patients and compliance with medication. Schizophr Bull 2001;27:149-155
8. Drake RE, Osher FC, Wallach MA. Alcohol use and abuse in schizophrenia. J Nerv Ment Dis 1989;177:404-414
9. Kashner TM, Rader LE, Rodell DE, et al. Family characteristics, substance abuse and hospitalization patterns of patients with schizophrenia. Hosp Community Psychiatry 1991;42:195-197
10. Owen RR, Fischer EP, Booth BM, et al. Medication non-compliance and substance abuse among patients with schizophrenia. Psychiatr Serv 1996; 47:853-858
11. Oehl MA, Burns T, Kemmler G, et al. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication. Pharmacopsychiatry. In press
12. Hummer M, Fleischhacker WW. Ways of improving compliance. In: Lader M, Naber D, eds. Difficult Clinical Problems in Psychiatry. London, England: Martin Dunitz; 1999:229-238
13. Hofer A, Kemmler G, Eder U, et al. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia. J Clin Psychiatry 2002;63:49-53
14. Sullivan G, Ells KB, Morgenstern H, et al. Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. Am J Psychiatry 1995;152:1749-1756
15. Irwin DS, Weitzell WD, Morgan DW. Phenothiazine intake and staff attitudes. Am J Psychiatry 1971;127:1631-1635
16. Tamminga CA, Schulz SC. Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology, vol 1. New York, NY: Raven Press; 1991
17. Nelson AA Jr, Gold BH, Hutchinson RA, et al. Drug default among schizophrenic patients. Am J Hosp Pharm 1975;32:1237-1242
18. Bäuml J, Kissling W, Buttner P, et al. Informationszentrierte Patientenund Angehörigengruppen zur Complianceverbesserung bei schizophrenen Psychosen. Verhaltenstherapie 1993;3(2 suppl):1-96
19. Kemp R, Kirov G, Everitt B, et al. Randomized controlled trial of compliance therapy. Br J Psychiatry 1998;172:413-419
20. Albus M, Burkes S, Scherer J. Welche Faktoren beeinflussen die Medikamentencompliance? Psychiatr Prax 1995;22:228-230
21. Marder SR. Facilitating compliance with antipsychotic medication. J Clin Psychiatry 1998;59(suppl 3):21-25
22. Van Putten R, May PRA, Marder SR. Akathisia with haloperidol and thiothixene. Arch Gen Psychiatry 1984;41:1036-1039
23. Hummer M, Kemmler G, Kurz M, et al. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 1999;156:631-633
24. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150:1881-1884
25. Young JL, Zonana HV, Shepler L. Medication non-compliance in schizophrenia: codification and update. Bull Am Acad Psychiatr Law 1986;14: 105-122
26. Buchanan A. A two year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 1992;22:787-797
27. Weiden P, Rapkin B, Zygmund A, et al. Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen. Psychiatr Serv 1995;46:1049-1054